Purchase Order FA486121P0016
- Not listed
- This contract was awarded by the Department of the Air Force Air Combat Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE RP2.1 PANELS. The contract is a firm fixed-price purchase order with a potential value of $213,463.86 and a completion date of August 6, 2021. No set-aside was used for this award. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards, including from the...
- This federal contract was awarded by the Department of the Air Force Air Combat Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $168,000 firm-fixed-price purchase order is for the delivery of FILMARRAY TORCH MODULE BOX. Biofire Diagnostics has received numerous federal contract awards as a prime contractor to provide a variety of goods and services related to infectious disease testing, including under...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company, was issued by the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base. The $181,500 firm fixed-price purchase order is for supplies related to COVID-19 testing. The contract has no set-aside designation, indicating open competition. Biofire Diagnostics is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) and Blanket...
- This federal contract award is for the procurement of FILM ARRAY diagnostic products and services from Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract has a firm fixed price of $575,133.07 and was awarded by the Department of the Air Force Materiel Command Test Center on September 5, 2017, with a completion date of September 14, 2020. The contract does not have a set-aside designation. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease...
- This is a federal contract award from the Department of the Army Medical Command to Biofire Diagnostics LLC, a for-profit, foreign-owned biotech company, for the delivery of Respiratory Panel Kits. The contract has a firm fixed price of $665,402.10 and a completion date of September 30, 2020. No set-aside designation was used. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to provide a variety of...
- This is a firm fixed-price purchase order awarded by the Department of the Air Force Air Combat Command to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for COVID-19 BIOFIRE FILMARRAY TORCH MODULES. The potential value of the contract is $112,000.00. The contract is not designated as a set-aside. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to...
- The Department of the Army Medical Command awarded a firm-fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, on December 19, 2017 for the supply of a respiratory panel IVD test kit with 30 tests. The contract has a potential value of $3,044,790.00 and a completion date of September 30, 2020. No set-aside designation was used. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal...
- This federal contract award, with the ID FA480017P0044, was made by the Air Combat Command to Biofire Diagnostics LLC for the provision of BIOFIRE TORCH MODULE - INFECTIOUS DISEASE TESTING. The $98,730.66 firm fixed price contract has a completion date of July 15, 2017. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contract awards, including blanket purchase agreements and indefinite delivery contracts,...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for the supply of BIOFIRE RESPIRATORY PANELS RP2.1 with a potential value of $233,601.96. The contract was awarded by the Department of the Air Force Air Combat Command, under a Firm Fixed Price purchase order, with the place of performance at Nellis AFB, NV. This award is not designated as a set-aside. Biofire Diagnostics LLC is the leader in syndromic infectious disease testing and has received numerous prior federal contract awards as a prime contractor to provide a variety of goods and services related to infectious disease testing, including for the Veterans Health Administration, Defense Health Agency, and Indian Health Service. This specific award appears to be part of Biofire's broader contracting vehicles with these federal agencies to procure diagnostic testing products and services on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $0 | 12/1/20 | |
| Not listed | Not listed | $233.6k | 11/5/20 |